UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming

Genome Biology, 2015-03, Vol.16 (1), p.59-59, Article 59

2015

Volltextzugriff (PDF)

Characterization of the imprinting signature of mouse embryo fibroblasts by RNA deep sequencing

Nucleic acids research, 2014-02, Vol.42 (3), p.1772-1783

2014

Volltextzugriff (PDF)

High type I error and misrepresentations in search for transgenerational epigenetic inheritance: response to Guerrero-Bosagna

Genome Biology, 2016-07, Vol.17 (1), p.154-154, Article 154

2016

Volltextzugriff (PDF)

Abstract 4314: Using antioxidant to enhance liver cancer preventive effect of n-3 PUFAs

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4314-4314

2016

Volltextzugriff (PDF)

Effect of E-Vaping on Kidney Health in Mice Consuming a High-Fat Diet

Nutrients, 2023-07, Vol.15 (14), p.3140

2023

Volltextzugriff (PDF)

Sex Differences in Genetic Associations With Longevity

JAMA network open, 2018-08, Vol.1 (4), p.e181670

2018

Volltextzugriff (PDF)

Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling

Proceedings of the National Academy of Sciences - PNAS, 2024-07, Vol.121 (29)

2024

Volltextzugriff (PDF)

Comparison of vaginal microbiota in gynecologic cancer patients pre‐ and post‐radiation therapy and healthy women

Cancer medicine (Malden, MA), 2020-06, Vol.9 (11), p.3714-3724

2020

Volltextzugriff (PDF)

Factors Associated With the Trend of Physical and Chemical Restraint Use Among Long-Term Care Facility Residents in Hong Kong: Data From an 11-Year Observational Study

Journal of the American Medical Directors Association, 2017-12, Vol.18 (12), p.1043-1048

2017

Volltextzugriff (PDF)

Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial

Annals of emergency medicine, 2019-06, Vol.73 (6), p.650-661

2019

Volltextzugriff (PDF)

Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial

Journal of the American College of Surgeons, 2018-12, Vol.227 (6), p.587-595

2018

Volltextzugriff (PDF)

Prevalence of medication adherence and its associated factors among community-dwelling Chinese older adults in Hong Kong

Geriatrics & gerontology international, 2015-06, Vol.15 (6), p.789-796

2015

Volltextzugriff (PDF)

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

Modern pathology, 2022-10, Vol.35 (10), p.1362-1369

2022

Volltextzugriff (PDF)

Acute respiratory distress syndrome, acute kidney injury, and mortality after trauma are associated with increased circulation of syndecan-1, soluble thrombomodulin, and receptor for advanced glycation end products

The journal of trauma and acute care surgery, 2024-02, Vol.96 (2), p.319-325

2024

Volltextzugriff (PDF)

TEG Lysis Shutdown Represents Coagulopathy in Bleeding Trauma Patients: Analysis of the PROPPR Cohort

Shock (Augusta, Ga.), 2019-03, Vol.51 (3), p.273-283

2019

Volltextzugriff (PDF)

Onset of Coagulation Function Recovery Is Delayed in Severely Injured Trauma Patients with Venous Thromboembolism

Journal of the American College of Surgeons, 2017-07, Vol.225 (1), p.42-51

2017

Volltextzugriff (PDF)

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial

Blood advances, 2018-07, Vol.2 (14), p.1696-1704

2018

Volltextzugriff (PDF)

Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants

Journal of medicinal chemistry, 2003-10, Vol.46 (21), p.4405-4418

2003

Volltextzugriff (PDF)

A generalized model for the conversion from CT numbers to linear attenuation coefficients

IEEE transactions on nuclear science, 2003-10, Vol.50 (5), p.1510-1515

2003

Volltextzugriff (PDF)

Prevalence of medication adherence and its associated factors among community‐dwelling C hinese older adults in H ong K ong

Geriatrics & gerontology international, 2015-06, Vol.15 (6), p.789-796

2015

Volltextzugriff (PDF)

Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

Journal of medicinal chemistry, 2003-12, Vol.46 (25), p.5298-5315

2003

Volltextzugriff (PDF)

1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydro xy- N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazo lo-[3 ,4- c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa

Bioorganic & medicinal chemistry letters, 2006-01, Vol.16 (15), p.4141-4147

2006

Volltextzugriff (PDF)

Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1

Journal of medicinal chemistry, 2003-12, Vol.46 (25), p.5298-5315

2003

Volltextzugriff (PDF)

Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl- N - [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1 H -pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

Journal of medicinal chemistry, 2003-12, Vol.46 (25), p.5298-5315

2003

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(25)
Tagungsberichte
(1)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(17)
Humans
(12)
Male
(11)
Female
(10)
Middle Aged
(6)
Adult
(5)
Animals
(5)
Surgery
(5)
Aged, 80 And Over
(3)
Biological And Medical Sciences
(3)
Blood. Blood Coagulation. Reticuloendothelial System
(3)
Deoxyribonucleic Acid
(3)
Dna
(3)
Factor Xa Inhibitors
(3)
General & Internal Medicine
(3)
Genomes
(3)
Genomics
(3)
Medical Sciences
(3)
Mice
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming

Characterization of the imprinting signature of mouse embryo fibroblasts by RNA deep sequencing

High type I error and misrepresentations in search for transgenerational epigenetic inheritance: response to Guerrero-Bosagna

Abstract 4314: Using antioxidant to enhance liver cancer preventive effect of n-3 PUFAs

Effect of E-Vaping on Kidney Health in Mice Consuming a High-Fat Diet

Sex Differences in Genetic Associations With Longevity

Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling

Comparison of vaginal microbiota in gynecologic cancer patients pre‐ and post‐radiation therapy and healthy women

Factors Associated With the Trend of Physical and Chemical Restraint Use Among Long-Term Care Facility Residents in Hong Kong: Data From an 11-Year Observational Study

Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial

Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial

Prevalence of medication adherence and its associated factors among community-dwelling Chinese older adults in Hong Kong

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

Acute respiratory distress syndrome, acute kidney injury, and mortality after trauma are associated with increased circulation of syndecan-1, soluble thrombomodulin, and receptor for advanced glycation end products

TEG Lysis Shutdown Represents Coagulopathy in Bleeding Trauma Patients: Analysis of the PROPPR Cohort

Onset of Coagulation Function Recovery Is Delayed in Severely Injured Trauma Patients with Venous Thromboembolism

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial

Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants

A generalized model for the conversion from CT numbers to linear attenuation coefficients

Prevalence of medication adherence and its associated factors among community‐dwelling C hinese older adults in H ong K ong

1-[3-Aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-[2′-(3-( R)-hydroxy- N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4- c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa

Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydro xy- N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazo lo-[3 ,4- c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa

Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1

Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl- N - [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1 H -pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

Suchergebnisse filtern